0001628280-26-031680
SEC filingRockwell Medical, Inc. furnished an updated corporate presentation on May 7, 2026, as Exhibit 99.1 to its Form 8-K, disclosing no new financial results, material agreements, executive changes, or other substantive corporate events beyond the presentation update.
This filing constitutes a routine disclosure under Regulation FD to disseminate updated investor-facing materials. The furnished corporate presentation (Exhibit 99.1) serves informational and communications purposes only; the 8-K text explicitly states that neither the report nor the exhibit is 'filed' under the Exchange Act and carries no Section 18 liability. No financial results, forward-looking guidance, management changes, capital actions, or material transactions are disclosed in the filing body or referenced exhibits. Investors should treat this as a non-event from a fundamental or compliance standpoint — it reflects standard corporate communications hygiene rather than a material development affecting operations, liquidity, governance, or regulatory status.